Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Lower Extremity Functional Scale (LEFS) for Ankle Disorders

Sep 24, 2013/Test & Measure

Measures lower extremity musculoskeletal function.

Medicare Postacute Care Reform

Physical therapy services represent a significant portion of Medicare expenditures in post-acute care settings.

Rivermead Post-Concussion Symptoms Questionnaire (RPQ)

Jun 5, 2017/Test & Measure

Self-report or clinician-administered questionnaire to measure severity of 16 identified postconcussive symptoms.

Fatigue Severity Scale

Jun 5, 2017/Test & Measure

FSS is a unidimensional self-report questionnaire that measures how fatigue impacts one’s ability to function in the last week.

QuickDASH

May 25, 2017/Test & Measure

This is a measure of disability and symptoms in patients with musculoskeletal disorders that is region specific to the upper limb.

APTA Academy of Orthopaedic Physical Therapy: Knee Pain and Mobility Impairments: Meniscal and Articular Cartilage Lesions, Revision 2018 (CPG+)

Jan 31, 2018/CPG

This guideline provides recommendations related to the examination and treatment of patients with meniscal and articular cartilage lesions.

What's New at ChoosePT.com: Expanded Consumer Info, Growing Directory of PTs

Jun 14, 2022/Roundup

APTA members benefit from millions of consumer visits and an enriched consumer-focused website. Here's what’s new.

Time to Brush Up on Falls Prevention Knowledge and Skills

Sep 16, 2024/News

For Falls Prevention Awareness Week — and October's National Physical Therapy Month — here's a roundup of resources.

Use APTA's Award-Winning Tool to Comment on 2025 Home Health Proposed Rule

Aug 7, 2024/News

The proposed 2025 Home Health rule includes several provisions that the physical therapy community needs to weigh in on. Deadline is Aug. 26.

Physical Therapy and Occupational Therapy Provide Significant Rehabilitative Value in Postacute Care

Apr 5, 2021/Statement

Study across 1.4 million Medicare cases indicates patients receiving these therapies have better quality of life and fewer hospital readmissions.